Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.
Fiche publication
Date publication
novembre 2022
Journal
Clinical and translational radiation oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAIVRE Jean-Christophe
Tous les auteurs :
Vilotte F, Pasquier D, Blanchard P, Supiot S, Khalifa J, Schick U, Lacornerie T, Vieillevigne L, Marre D, Chapet O, Latorzeff I, Magne N, Meyer E, Cao K, Belkacemi Y, Bibault JE, Berge-Lefranc M, Faivre JC, Gnep K, Guimas V, Hasbini A, Langrand-Escure J, Hennequin C, Graff P
Lien Pubmed
Résumé
The relevance of metastasis-directed stereotactic body radiation therapy (SBRT) remains to be demonstrated through phase III trials. Multiple SBRT procedures have been published potentially resulting in a disparity of practices. Therefore, the french society of urological radiation oncolgists (GETUG) recognized the need for joint expert consensus guidelines for metastasis-directed SBRT in order to standardize practice in trials carried out by the group.
Mots clés
Metastasis-directed, Non-spine bone metastasis, Oligometastatic, Spine bone metastasis, Stereotactic radiation therapy, Stereotaxy
Référence
Clin Transl Radiat Oncol. 2022 11;37:33-40